A clinical supply forecast is never static. Learn how to turn changing demand, constrained supply, and uncertainty into decisions that protect inventory and study continuity.
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
ON-DEMAND WEBINARS
Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1254705026 clinical supplies]( "Using Tech Enabled Solutions To Boost Productivity And Sustainability")
Using Tech Enabled Solutions To Boost Productivity And SustainabilityHow can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
![Doctors discussing patient data-GettyImages-2214031965]( "Building Better Resilience Into Your Clinical Supply Strategy")
Building Better Resilience Into Your Clinical Supply StrategyReliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
![GettyImages-184945838-cold-chain-cryopreservation]( "Building A Global Cell And Gene Supply Chain Serving Personalized Medicine")
Building A Global Cell And Gene Supply Chain Serving Personalized MedicineClinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.
-
![GettyImages-1189150676-Medicinal_Marijuana_Cannabis_ControlledSubstance]( "Controlled Substances In Clinical Trials")
Controlled Substances In Clinical TrialsHandling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
![clinical-trial-supply-challenges-GettyImages-2161372208]( "From Bench To Breakthrough: How Custom Kitting Fuels Precision Trials")
From Bench To Breakthrough: How Custom Kitting Fuels Precision TrialsReduce trial variability and ensure protocol compliance with standardized custom kitting that transforms complex sample collection into a streamlined, strategic advantage for clinical success.
-
![GettyImages-1429005105-scientist-ipad-software-management]( "Choosing RTSM? Evaluate The Team Running It, Not Just The Software")
Choosing RTSM? Evaluate The Team Running It, Not Just The SoftwareHigh-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
![7 Seven Tips GettyImages-1450702003]( "7 Key Considerations For Designing The Optimal IRT/RTSM")
7 Key Considerations For Designing The Optimal IRT/RTSMSponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
![GettyImages-1212860058 clinical trial patient]( "24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments")
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical ShipmentsGet an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
![Singota-DSC03221]( "Developmental Testing Of IV Solutions")
Developmental Testing Of IV SolutionsAs IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.
-
![Getty-1652511983-supply-chain-management]( "The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems")
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented SystemsHere we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
